PDB Short entry for 2MIP HEADER HYDROLASE/HYDROLASE INHIBITOR 03-JUN-93 2MIP TITLE CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 TITLE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON TITLE 3 WITH HIV-1 PROTEASE STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-2 PROTEASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INHIBITOR BI-LA-398; COMPND 7 CHAIN: E, F, G, H; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 2; SOURCE 3 ORGANISM_TAXID: 11709; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2 KEYWDS ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.TONG,S.PAV,C.PARGELLIS,F.DO,D.LAMARRE,P.C.ANDERSON REVDAT 6 14-AUG-19 2MIP 1 REMARK REVDAT 5 17-JUL-19 2MIP 1 REMARK LINK REVDAT 4 13-JUL-11 2MIP 1 VERSN REVDAT 3 24-FEB-09 2MIP 1 VERSN REVDAT 2 15-JAN-95 2MIP 1 REMARK REVDAT 1 31-OCT-93 2MIP 0 JRNL AUTH L.TONG,S.PAV,C.PARGELLIS,F.DO,D.LAMARRE,P.C.ANDERSON JRNL TITL CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE JRNL TITL 2 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND JRNL TITL 3 COMPARISON WITH HIV-1 PROTEASE STRUCTURES. JRNL REF PROC.NATL.ACAD.SCI.USA V. 90 8387 1993 JRNL REFN ISSN 0027-8424 JRNL PMID 8378311 JRNL DOI 10.1073/PNAS.90.18.8387 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 16845 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3236 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 90 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : NULL ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MIP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178371. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.45000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 104.17500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 34.72500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, F, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE E 3 O REMARK 470 PHE F 3 O REMARK 470 PHE G 3 O REMARK 470 PHE H 3 O REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF INHIBITOR BI-LA-398 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF INHIBITOR BI-LA-398 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN G OF INHIBITOR BI-LA-398 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN H OF INHIBITOR BI-LA-398 DBREF 2MIP A 1 99 UNP P04584 POL_HV2RO 86 184 DBREF 2MIP B 1 99 UNP P04584 POL_HV2RO 86 184 DBREF 2MIP C 1 99 UNP P04584 POL_HV2RO 86 184 DBREF 2MIP D 1 99 UNP P04584 POL_HV2RO 86 184 DBREF 2MIP E 1 7 PDB 2MIP 2MIP 1 7 DBREF 2MIP F 1 7 PDB 2MIP 2MIP 1 7 DBREF 2MIP G 1 7 PDB 2MIP 2MIP 1 7 DBREF 2MIP H 1 7 PDB 2MIP 2MIP 1 7 SEQRES 1 A 99 PRO GLN PHE SER LEU TRP LYS ARG PRO VAL VAL THR ALA SEQRES 2 A 99 TYR ILE GLU GLY GLN PRO VAL GLU VAL LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP SER ILE VAL ALA GLY ILE GLU LEU GLY SEQRES 4 A 99 ASN ASN TYR SER PRO LYS ILE VAL GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE ASN THR LYS GLU TYR LYS ASN VAL GLU ILE GLU SEQRES 6 A 99 VAL LEU ASN LYS LYS VAL ARG ALA THR ILE MET THR GLY SEQRES 7 A 99 ASP THR PRO ILE ASN ILE PHE GLY ARG ASN ILE LEU THR SEQRES 8 A 99 ALA LEU GLY MET SER LEU ASN LEU SEQRES 1 B 99 PRO GLN PHE SER LEU TRP LYS ARG PRO VAL VAL THR ALA SEQRES 2 B 99 TYR ILE GLU GLY GLN PRO VAL GLU VAL LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP SER ILE VAL ALA GLY ILE GLU LEU GLY SEQRES 4 B 99 ASN ASN TYR SER PRO LYS ILE VAL GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE ASN THR LYS GLU TYR LYS ASN VAL GLU ILE GLU SEQRES 6 B 99 VAL LEU ASN LYS LYS VAL ARG ALA THR ILE MET THR GLY SEQRES 7 B 99 ASP THR PRO ILE ASN ILE PHE GLY ARG ASN ILE LEU THR SEQRES 8 B 99 ALA LEU GLY MET SER LEU ASN LEU SEQRES 1 C 99 PRO GLN PHE SER LEU TRP LYS ARG PRO VAL VAL THR ALA SEQRES 2 C 99 TYR ILE GLU GLY GLN PRO VAL GLU VAL LEU LEU ASP THR SEQRES 3 C 99 GLY ALA ASP ASP SER ILE VAL ALA GLY ILE GLU LEU GLY SEQRES 4 C 99 ASN ASN TYR SER PRO LYS ILE VAL GLY GLY ILE GLY GLY SEQRES 5 C 99 PHE ILE ASN THR LYS GLU TYR LYS ASN VAL GLU ILE GLU SEQRES 6 C 99 VAL LEU ASN LYS LYS VAL ARG ALA THR ILE MET THR GLY SEQRES 7 C 99 ASP THR PRO ILE ASN ILE PHE GLY ARG ASN ILE LEU THR SEQRES 8 C 99 ALA LEU GLY MET SER LEU ASN LEU SEQRES 1 D 99 PRO GLN PHE SER LEU TRP LYS ARG PRO VAL VAL THR ALA SEQRES 2 D 99 TYR ILE GLU GLY GLN PRO VAL GLU VAL LEU LEU ASP THR SEQRES 3 D 99 GLY ALA ASP ASP SER ILE VAL ALA GLY ILE GLU LEU GLY SEQRES 4 D 99 ASN ASN TYR SER PRO LYS ILE VAL GLY GLY ILE GLY GLY SEQRES 5 D 99 PHE ILE ASN THR LYS GLU TYR LYS ASN VAL GLU ILE GLU SEQRES 6 D 99 VAL LEU ASN LYS LYS VAL ARG ALA THR ILE MET THR GLY SEQRES 7 D 99 ASP THR PRO ILE ASN ILE PHE GLY ARG ASN ILE LEU THR SEQRES 8 D 99 ALA LEU GLY MET SER LEU ASN LEU SEQRES 1 E 7 PHE VAL PHE LEU GLU ILE NH2 SEQRES 1 F 7 PHE VAL PHE LEU GLU ILE NH2 SEQRES 1 G 7 PHE VAL PHE LEU GLU ILE NH2 SEQRES 1 H 7 PHE VAL PHE LEU GLU ILE NH2 HET NH2 E 7 1 HET NH2 F 7 1 HET NH2 G 7 1 HET NH2 H 7 1 HETNAM NH2 AMINO GROUP FORMUL 5 NH2 4(H2 N) FORMUL 9 HOH *90(H2 O) HELIX 1 1 GLY A 86 GLY A 94 1 9 HELIX 2 2 GLY B 86 LEU B 93 1 8 HELIX 3 3 GLY C 86 LEU C 93 1 8 HELIX 4 4 GLY D 86 GLY D 94 1 9 SHEET 1 A 4 GLN A 2 SER A 4 0 SHEET 2 A 4 SER B 96 ASN B 98 -1 O LEU B 97 N PHE A 3 SHEET 3 A 4 SER A 96 ASN A 98 -1 O SER A 96 N ASN B 98 SHEET 4 A 4 GLN B 2 SER B 4 -1 N PHE B 3 O LEU A 97 SHEET 1 B 4 GLN C 2 SER C 4 0 SHEET 2 B 4 SER D 96 ASN D 98 -1 N LEU D 97 O PHE C 3 SHEET 3 B 4 SER C 96 ASN C 98 -1 O SER C 96 N ASN D 98 SHEET 4 B 4 GLN D 2 SER D 4 -1 N PHE D 3 O LEU C 97 LINK C ILE E 6 N NH2 E 7 1555 1555 1.33 LINK C ILE F 6 N NH2 F 7 1555 1555 1.31 LINK C ILE G 6 N NH2 G 7 1555 1555 1.33 LINK C ILE H 6 N NH2 H 7 1555 1555 1.34 LINK N NH2 G 7 N PHE E 1 1555 1555 1.55 LINK N NH2 H 7 N PHE F 1 1555 1555 1.79 SITE 1 AC1 29 ASP A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC1 29 ASP A 30 ILE A 32 VAL A 47 GLY A 48 SITE 3 AC1 29 GLY A 49 ILE A 50 PRO A 81 ILE A 82 SITE 4 AC1 29 ILE A 84 ARG B 8 ASP B 25 GLY B 27 SITE 5 AC1 29 ASP B 29 GLY B 48 GLY B 49 ILE B 50 SITE 6 AC1 29 TYR D 14 HOH E 501 PHE G 1 VAL G 2 SITE 7 AC1 29 PHE G 3 LEU G 4 GLU G 5 ILE G 6 SITE 8 AC1 29 NH2 G 7 SITE 1 AC2 31 ASN B 40 ASN B 41 GLU B 65 LEU C 23 SITE 2 AC2 31 ASP C 25 GLY C 27 ALA C 28 ASP C 29 SITE 3 AC2 31 GLY C 48 GLY C 49 ILE C 50 ILE C 82 SITE 4 AC2 31 ILE C 84 ASP D 25 GLY D 27 ALA D 28 SITE 5 AC2 31 ASP D 29 ASP D 30 VAL D 47 GLY D 48 SITE 6 AC2 31 GLY D 49 PRO D 81 ILE D 82 HOH F 701 SITE 7 AC2 31 PHE H 1 VAL H 2 PHE H 3 LEU H 4 SITE 8 AC2 31 GLU H 5 ILE H 6 NH2 H 7 SITE 1 AC3 28 ASP A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC3 28 ASP A 30 GLY A 48 GLY A 49 ILE A 50 SITE 3 AC3 28 PRO A 81 ILE A 84 ARG B 8 ASP B 25 SITE 4 AC3 28 GLY B 27 ALA B 28 ASP B 29 ASP B 30 SITE 5 AC3 28 VAL B 47 GLY B 48 ILE B 50 HOH B 505 SITE 6 AC3 28 PHE E 1 VAL E 2 PHE E 3 LEU E 4 SITE 7 AC3 28 GLU E 5 ILE E 6 NH2 E 7 HOH E 501 SITE 1 AC4 32 TYR B 14 ASN B 40 ASN B 41 TYR B 42 SITE 2 AC4 32 ASP C 25 GLY C 27 ALA C 28 ASP C 29 SITE 3 AC4 32 ASP C 30 VAL C 47 GLY C 48 GLY C 49 SITE 4 AC4 32 ILE C 50 ILE C 82 ASP D 25 GLY D 27 SITE 5 AC4 32 ALA D 28 ASP D 29 VAL D 47 GLY D 48 SITE 6 AC4 32 GLY D 49 ILE D 50 PRO D 81 ILE D 82 SITE 7 AC4 32 PHE F 1 VAL F 2 PHE F 3 LEU F 4 SITE 8 AC4 32 GLU F 5 ILE F 6 NH2 F 7 HOH F 701 CRYST1 55.100 55.100 138.900 90.00 90.00 90.00 P 43 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018149 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018149 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007199 0.00000